Blue Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$491K Sell
2,119
-842
-28% -$208K 0.01% 491
2026
Q2
$713K Sell
2,961
-42
-1% -$9.2K 0.01% 377
2026
Q1
$568K Buy
3,003
+10
+0.3% +$1.75K 0.01% 449
2025
Q4
$509K Sell
2,993
-268
-8% -$41.1K 0.01% 475
2025
Q3
$430K Buy
3,261
+109
+3% +$13.1K ﹤0.01% 537
2025
Q2
$334K Buy
3,152
+200
+7% +$21.7K ﹤0.01% 595
2025
Q1
$366K Buy
2,952
+1,185
+67% +$155K ﹤0.01% 500
2024
Q4
$218K Buy
1,767
+750
+74% +$88.4K ﹤0.01% 615
2024
Q3
$109K Sell
1,017
-290
-22% -$31.8K ﹤0.01% 1179
2024
Q2
$157K Buy
1,307
+257
+24% +$28.3K ﹤0.01% 800
2024
Q1
$126K Buy
1,050
+1,036
+7,400% +$127K ﹤0.01% 646
2023
Q4
$2K Buy
+14
New +$1.75K ﹤0.01% 2160
2023
Q3
– Sell
-6
Closed -$1K – 2165
2023
Q2
$1K Sell
6
-37
-86% -$4.98K ﹤0.01% 1865
2023
Q1
$7K Buy
+43
New +$6.36K ﹤0.01% 1699
2022
Q4
– Sell
-5
Closed -$1K – 2347
2022
Q3
$1K Hold
5
– – ﹤0.01% 1939
2022
Q2
$1K Buy
+5
New +$770 ﹤0.01% 1789

Other funds holding JAZZ

Blue Trust's JAZZ Position: Q3 2026 in Review

Blue Trust reduced its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q3 2026, selling an estimated $208K and leaving 2,119 shares worth $491K. The position accounts for 0.01% of the portfolio, ranked #491.

Blue Trust first reported a position in JAZZ in Q2 2022 and has held it in 16 quarters since. The position peaked at $713K in Q2 2026. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Blue Trust held 2,119 shares of Jazz Pharmaceuticals worth $491K as of Q3 2026.
  • Blue Trust sold 842 Jazz Pharmaceuticals shares in Q3 2026, an estimated $208K.
  • Jazz Pharmaceuticals made up 0.01% of Blue Trust's portfolio in Q3 2026, its #491 holding.
  • Blue Trust first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust's Jazz Pharmaceuticals position peaked at $713K in Q2 2026.
  • 538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.